Analgesic Efficacy of Capsaicin 8% Patch (QUTENZA®) in Coccygodygnia

NCT05983263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2023-08-09

No results posted yet for this study

Summary

A retrospective study over a period of 6 years to explore analgesic efficacy of 8% Capsaicin patch (QUTENZA®) in coccygodynic patients, as well as neuropathic predictive factors of therapeutic response.

Conditions

  • Coccyx Disorder

Interventions

DRUG

Capsaicin

Capsaicin 8% patch (QUTENZA) apposed in coccygeal area

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-15
Primary Completion
2023-12-17
Completion
2023-12-21

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05983263 on ClinicalTrials.gov